3 Comments
User's avatar
Biotech Bagholder's avatar

Great read

Expand full comment
Steve Cheung's avatar

Thanks for trip down memory lane.

This trial came out when I was a fellow. It has guided my decision for identifying NSTEMI pts who would benefit from early invasive strategy since day 1 of my practice. The TIMI risk score was particularly useful in the days before smart phones, as there was no way back then to quickly calculate GRACE score at bedside but I could easily remember a 7 point scoring scale.

It should also be noted that subsequent trials like ICTUS showed that elevated trop alone in NSTEMI was a poor indicator of benefit of early invasive strategy. That further cemented my use of TIMI risk score in my hospital practice.

Expand full comment
medstudent's avatar

thank you

Expand full comment